Wells Fargo & Company Boosts RxSight (NASDAQ:RXST) Price Target to $27.00
RxSight (NASDAQ:RXST – Get Rating) had its price target hoisted by Wells Fargo & Company from $17.00 to $27.00 in a research note issued to investors on Monday morning, The Fly reports. RXST has been the topic of several other reports. JPMorgan Chase & Co. cut their target price on shares of RxSight from $22.00 […]